Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery
Status:
Not yet recruiting
Trial end date:
2022-05-02
Target enrollment:
Participant gender:
Summary
For successful intraoperative neuromonitoring (IONM), adequate reversal of neuromuscular
blocking agent is a prerequisite in thyroid surgery with .
The aim of this study is to investigate the feasibility of neostigmine just after tracheal
intubation on the IONM in thyroid surgery.